Sox9-expressing cells promote regeneration after radiation-induced lung injury via the PI3K/AKT pathway. 2021

Shuang Chen, and Kang Li, and Xinqi Zhong, and Ganping Wang, and Xiaocheng Wang, and Maosheng Cheng, and Jie Chen, and Zhi Chen, and Jianwen Chen, and Caihua Zhang, and Gan Xiong, and Xiuyun Xu, and Demeng Chen, and Heping Li, and Liang Peng
Center for Translational Medicine, Institute of Precision Medicine, Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.

Radiation-induced lung injury (RILI) is considered one of the most common complications of thoracic radiation. Recent studies have focused on stem cell properties to obtain ideal therapeutic effects, and Sox9 has been reported to be involved in stem cell induction and differentiation. However, whether Sox9-expressing cells play a role in radiation repair and regeneration remains unknown. We successfully obtained Sox9CreER, RosatdTomato and RosaDTA mice and identified Sox9-expressing cells through lineage tracing. Then, we evaluated the effects of the ablation of Sox9-expressing cells in vivo. Furthermore, we investigated the underlying mechanism of Sox9-expressing cells during lung regeneration via an online single-cell RNA-seq dataset. In our study, we demonstrated that Sox9-expressing cells promote the regeneration of lung tissues and that ablation of Sox9-expressing cells leads to severe phenotypes after radiation damage. In addition, analysis of an online scRNA-Seq dataset revealed that the PI3K/AKT pathway is enriched in Sox9-expressing cells during lung epithelium regeneration. Finally, the AKT inhibitor perifosine suppressed the regenerative effects of Sox9-expressing cells and the AKT pathway agonist promotes proliferation and differentiation. Taken together, the findings of our study suggest that Sox9-expressing cells may serve as a therapeutic target in lung tissue after RILI.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D011832 Radiation Injuries Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES. Radiation Sickness,Radiation Syndrome,Injuries, Radiation,Injury, Radiation,Radiation Injury,Radiation Sicknesses,Radiation Syndromes,Sickness, Radiation,Sicknesses, Radiation,Syndrome, Radiation,Syndromes, Radiation
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013491 Suppressor Factors, Immunologic Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility (I-J) and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory. Immunologic Suppressor Factors,Suppressor T-Cell Factors,T-Cell Suppressive Factors,T-Suppressor Factors,Factors, Immunologic Suppressor,Factors, T Suppressor,Suppressor Factor (SF4),T Cell Suppressor Factors,Factors, Suppressor T-Cell,Factors, T-Cell Suppressive,Factors, T-Suppressor,Suppressive Factors, T-Cell,Suppressor Factors, T,Suppressor T Cell Factors,T Cell Suppressive Factors,T Suppressor Factors,T-Cell Factors, Suppressor
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D051057 Proto-Oncogene Proteins c-akt Protein-serine-threonine kinases that contain PLECKSTRIN HOMOLOGY DOMAINS and are activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. They play a major role in cell metabolism, growth, and survival as a core component of SIGNAL TRANSDUCTION. Three isoforms have been described in mammalian cells. akt Proto-Oncogene Protein,c-akt Protein,AKT1 Protein Kinase,AKT2 Protein Kinase,AKT3 Protein Kinase,Akt-alpha Protein,Akt-beta Protein,Akt-gamma Protein,Protein Kinase B,Protein Kinase B alpha,Protein Kinase B beta,Protein Kinase B gamma,Protein-Serine-Threonine Kinase (Rac),Proto-Oncogene Protein Akt,Proto-Oncogene Protein RAC,Proto-Oncogene Proteins c-akt1,Proto-Oncogene Proteins c-akt2,Proto-Oncogene Proteins c-akt3,RAC-PK Protein,Rac Protein Kinase,Rac-PK alpha Protein,Rac-PK beta Protein,Related to A and C-Protein,c-akt Proto-Oncogene Protein,Akt alpha Protein,Akt beta Protein,Akt gamma Protein,Akt, Proto-Oncogene Protein,Protein, akt Proto-Oncogene,Protein, c-akt Proto-Oncogene,Proteins c-akt1, Proto-Oncogene,Proteins c-akt2, Proto-Oncogene,Proteins c-akt3, Proto-Oncogene,Proto Oncogene Protein Akt,Proto Oncogene Protein RAC,Proto Oncogene Proteins c akt,Proto Oncogene Proteins c akt1,Proto Oncogene Proteins c akt2,Proto Oncogene Proteins c akt3,Proto-Oncogene Protein, akt,Proto-Oncogene Protein, c-akt,RAC PK Protein,RAC, Proto-Oncogene Protein,Rac PK alpha Protein,Rac PK beta Protein,Related to A and C Protein,akt Proto Oncogene Protein,alpha Protein, Rac-PK,c akt Proto Oncogene Protein,c-akt, Proto-Oncogene Proteins,c-akt1, Proto-Oncogene Proteins,c-akt2, Proto-Oncogene Proteins,c-akt3, Proto-Oncogene Proteins
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D055370 Lung Injury Damage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES. E-Cigarette Use-Associated Lung Injury,E-Cigarette or Vaping Product Use-Associated Lung Injury,EVALI,Vaping Product Use-Associated Lung Injury,Chronic Lung Injury,Lung Injuries,Pulmonary Injury,Chronic Lung Injuries,E Cigarette Use Associated Lung Injury,E Cigarette or Vaping Product Use Associated Lung Injury,EVALIs,Injuries, Lung,Injuries, Pulmonary,Injury, Lung,Injury, Pulmonary,Lung Injuries, Chronic,Lung Injury, Chronic,Pulmonary Injuries,Vaping Product Use Associated Lung Injury

Related Publications

Shuang Chen, and Kang Li, and Xinqi Zhong, and Ganping Wang, and Xiaocheng Wang, and Maosheng Cheng, and Jie Chen, and Zhi Chen, and Jianwen Chen, and Caihua Zhang, and Gan Xiong, and Xiuyun Xu, and Demeng Chen, and Heping Li, and Liang Peng
March 2023, Journal of orthopaedic translation,
Shuang Chen, and Kang Li, and Xinqi Zhong, and Ganping Wang, and Xiaocheng Wang, and Maosheng Cheng, and Jie Chen, and Zhi Chen, and Jianwen Chen, and Caihua Zhang, and Gan Xiong, and Xiuyun Xu, and Demeng Chen, and Heping Li, and Liang Peng
January 2022, Frontiers in pharmacology,
Shuang Chen, and Kang Li, and Xinqi Zhong, and Ganping Wang, and Xiaocheng Wang, and Maosheng Cheng, and Jie Chen, and Zhi Chen, and Jianwen Chen, and Caihua Zhang, and Gan Xiong, and Xiuyun Xu, and Demeng Chen, and Heping Li, and Liang Peng
May 2018, Molecular medicine reports,
Shuang Chen, and Kang Li, and Xinqi Zhong, and Ganping Wang, and Xiaocheng Wang, and Maosheng Cheng, and Jie Chen, and Zhi Chen, and Jianwen Chen, and Caihua Zhang, and Gan Xiong, and Xiuyun Xu, and Demeng Chen, and Heping Li, and Liang Peng
August 2020, Cell death & disease,
Shuang Chen, and Kang Li, and Xinqi Zhong, and Ganping Wang, and Xiaocheng Wang, and Maosheng Cheng, and Jie Chen, and Zhi Chen, and Jianwen Chen, and Caihua Zhang, and Gan Xiong, and Xiuyun Xu, and Demeng Chen, and Heping Li, and Liang Peng
September 2020, Brain and behavior,
Shuang Chen, and Kang Li, and Xinqi Zhong, and Ganping Wang, and Xiaocheng Wang, and Maosheng Cheng, and Jie Chen, and Zhi Chen, and Jianwen Chen, and Caihua Zhang, and Gan Xiong, and Xiuyun Xu, and Demeng Chen, and Heping Li, and Liang Peng
December 2018, Inflammation,
Shuang Chen, and Kang Li, and Xinqi Zhong, and Ganping Wang, and Xiaocheng Wang, and Maosheng Cheng, and Jie Chen, and Zhi Chen, and Jianwen Chen, and Caihua Zhang, and Gan Xiong, and Xiuyun Xu, and Demeng Chen, and Heping Li, and Liang Peng
January 2018, Molecular medicine reports,
Shuang Chen, and Kang Li, and Xinqi Zhong, and Ganping Wang, and Xiaocheng Wang, and Maosheng Cheng, and Jie Chen, and Zhi Chen, and Jianwen Chen, and Caihua Zhang, and Gan Xiong, and Xiuyun Xu, and Demeng Chen, and Heping Li, and Liang Peng
April 2018, Life sciences,
Shuang Chen, and Kang Li, and Xinqi Zhong, and Ganping Wang, and Xiaocheng Wang, and Maosheng Cheng, and Jie Chen, and Zhi Chen, and Jianwen Chen, and Caihua Zhang, and Gan Xiong, and Xiuyun Xu, and Demeng Chen, and Heping Li, and Liang Peng
January 2021, Frontiers in oncology,
Shuang Chen, and Kang Li, and Xinqi Zhong, and Ganping Wang, and Xiaocheng Wang, and Maosheng Cheng, and Jie Chen, and Zhi Chen, and Jianwen Chen, and Caihua Zhang, and Gan Xiong, and Xiuyun Xu, and Demeng Chen, and Heping Li, and Liang Peng
June 2020, Journal of receptor and signal transduction research,
Copied contents to your clipboard!